This story is from the CurrentWire archive. Coverage details reflect the last time it was updated.
Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again EXTON, Pa., Aug. 19, 2026 (GLOBE NEWSWIRE) — Lungpacer Medical Inc. today announced that its AeroPace System has been nominated for the 2026 Prix Galien USA Award for Best […]
Financial Post
Published by CurrentWire · First coverage
Compiled by CurrentWire News Desk
Summary based on reporting from Financial Post.
Automated coverage analysis
Generated automatically from the coverage listed on this page. CurrentWire adds no editorial claims.
Coverage
1 publication is covering this story.
How CurrentWire compiled this story
Financial Post (financialpost.com), a Tier B publisher, filed this report on . CurrentWire published this page 5 minutes later, on .
Filed under Health · United States · Press release. Topics extracted from this report, with other live CurrentWire stories mentioning each: FDA (none), Medical Nominated (none), Prix Galien USA Award (none), Best Medical Technology (none).
CurrentWire is a news discovery platform. This page summarizes and links to original reporting; full articles, imagery and copyright remain with the publishers listed above.